NCT01390610View on ClinicalTrials.gov

Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Diabetes Mellitus, Type 2Diabetic Blood Glucose Monitoring
Trial Locations (1)

55416

International Diabetes Center, Minneapolis

Sponsors

Collaborators (1)

Abbott Diabetes Care
All Listed Sponsors
collaborator

Abbott Diabetes Care

INDUSTRY

lead

HealthPartners Institute

OTHER

NCT01390610 - Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition | Biotech Hunter | Biotech Hunter